Ningbo Menovo Pharmaceutical Co.,Ltd.’s Net Profit Dropped 74.5% in First Three Quarters of 2023

Ningbo Menovo Pharmaceutical Co.,Ltd. (宁波美诺华药业股份有限公司) (603538.SH) reported a net profit of 60 million yuan in the first three quarters of 2023, down 74.5% year-on-year.

Meanwhile, the company posted 928.5 million yuan in revenue, down 24.6% year-on-year.

At the end of the reporting period, it had 4.7 billion yuan in total assets and 2.4 billion yuan in total liabilities, with a liability-to-asset ratio of 52.3%.